Vaccine-Preventable Diseases Clinical Trials

33 clinical trials for Vaccine-Preventable Diseases across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Playing Game to Learn About Children's Vaccine Project — RECRUITING · NA
• Safety and Immunogenicity of CVI-VZV-001 for Prevention of Herpes Zoster in Healthy Adults Age 50 Years and Above — RECRUITING · PHASE1
• A Phase Ⅲ Clinical Study to Evaluate Protective Efficacy and Safety of a Recombinant Herpes Zoster Vaccine — RECRUITING · PHASE3
• Herpes Virus Infections in Kidney Transplant Patients — ACTIVE_NOT_RECRUITING
• Hashtag HPV: HPV Vaccine Twitter Education Program — COMPLETED · NA
• Culturally Tailored HPV Psychoeducational Multimedia Intervention — COMPLETED · NA
• Maternal Immunization With Tetanus Toxoid, Reduced Diphtheria Toxoid, Reduced-dose (2 µg) Recombinant Pertussis Vaccine (TdaP2gen) and Its Effect on the Immune Response in Thai Infants up to 15-18 Months Old — NOT_YET_RECRUITING · PHASE4
• Impact of Reactogenicity of the 2024-2025 COVID-19 Vaccines on Health Care Workers and First Responders in the United States — COMPLETED · PHASE4
• Safety and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adults 50 Years of Age and Over — ACTIVE_NOT_RECRUITING · PHASE1
• Immunogenicity and Safety of I-HAV in Healthy Thai Children and Adolescents Lacking Protective Antibody After L-HAV — ACTIVE_NOT_RECRUITING · PHASE3
• Long-term Immunogenicity of L-HAV Vaccine Among Healthy Thai Children and Adolescents — ACTIVE_NOT_RECRUITING
• Game-Based Intervention to Promote HPV Vaccination — COMPLETED · NA
• Effectiveness, Immunogenicity and Safety of the Second Booster Dose of the Vaccine Against COVID-19 in the Elderly — COMPLETED
• The Efficacy of the 2023-2024 Updated COVID-19 Vaccines Against COVID-19 Infection — COMPLETED · PHASE4
• Reducing COVID-19 Vaccine Hesitancy Among Hispanic Parents — COMPLETED · NA
• Improving Vaccine Counseling Skills Among Residents Using Educational Modules and Standardized Patient Encounters — COMPLETED · NA
• Trial of the Immunogenicity, Safety, and Tolerability of rF1V Vaccine With CpG 1018® Adjuvant Compared With rF1V Vaccine in Adults 18 to 55 Years of Age — COMPLETED · PHASE2
• Safety and Immunogenicity of Two Dose Levels of OVX836 Influenza Vaccine as a Booster on Participants Previously Administered With OVX836 — COMPLETED · PHASE2
• Study to Evaluate the Safety and Immunogenicity of an HIV-1 Vaccine Regimen of Adjuvanted UVAX-1107 Followed by Adjuvanted UVAX-1107 or Adjuvanted UVAX-1197 in Healthy Subjects Aged 25-55 Years. — COMPLETED · PHASE1
• Building Engagement Using Financial Incentives Trial - Colorectal Cancer Screening — COMPLETED · NA
• Immunogenicity and Safety of Inactivated and Live-attenuated HAV Vaccine Among Thai Healthy Children and Adolescents — COMPLETED · PHASE3
• Vaccine Hesitancy in Patients with Solid Tumors: a Cross-sectional Single-center Survey — COMPLETED
• Immune Response Elicited by Concomitant Administration of Oral Typhoid Fever (Vivotif®) and Cholera (Dukoral®) Vaccines — COMPLETED · PHASE4
• An Evaluation of a Dynamic Web-Based Visualization of Community Immunity — COMPLETED · NA
• A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Prophylactic Hepatitis B Vaccine — COMPLETED · PHASE1
• Fine Needle aSpiration of Lymph nodEs to Study vAccine-induced Immunity — OTHER · NA
• Animal Bite Victims Seeking Medical Services at Concerned Hospitals — NOT_YET_RECRUITING
• A Study to Evaluate Safety and Tolerability of a Recombinant Herpes Zoster Vaccine — OTHER · PHASE1
• Trial to Evaluate the Safety, Tolerability, and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adult Volunteers — COMPLETED · PHASE1
• Volatility and Heterogeneity of Vaccine Sentiments Means Continuous Monitoring is Needed When Measuring Message Effectiveness — COMPLETED · NA
• Safety and Immunogenicity of 2 Doses Versus 1 Dose of Acellular Pertussis Vaccines Containing Genetically-detoxified Pertussis Toxin in Young Adults Previously Primed With Acellular Pertussis Vaccines — OTHER · PHASE2
• Pneumococcal Vaccination in Patients With Chronic Lymphocytic Leukaemia — OTHER
• Testing the Use of Prompts to Increase Adolescent Immunization Rates — COMPLETED · NA

Refine this search